Trial
NCT01230970
Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Ipsen
Collaborators
—
Condition
Breast Cancer
Intervention
BN83495
Why stopped
The futility analysis of study NCT00910091 in patients with endometrial cancer shows that the primary endpoint will not be reached.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-07